Immunotherapies Flashcards

1
Q

What are immunotherapies based on?

A

Immunomodulation

either suppression or activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Therapeutic molecules

A
  1. Small molecules: <500 Da, non-protein
  2. MAb(monoclonal antibodies)
  3. Therapeutic proteins: EC ligands/receptors e.g IL-2
  4. Vaccines, IVIG: stim endogenous ab prod or give passive ab dosage
  5. Immune cell based therapies e.g dendritic cell therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Immunotherapies: Main areas of application

A
  1. Anti-tumor
  2. Autoimmunity
  3. Immunodeficiencies
  4. Transplantation
  5. Allergies
  6. Autoinflamm diseases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

MAb= Monoclonal Antibodies

A

Bind to a specific epitop
Whole or fragment ab
Modified by conjugation- toxins, radioactive substances, binding of cytokines
Used for both suppression and stimulation
Can be bispecific: they can connect the target and effector cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MAb effector functions

A

Neutralization
Receptor blocking
Apoptosis through cross reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Production of MAb: cell types

A

Plasma cells

Myeloma cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Production of MAb plasma cells

A

No in vitro propagation
Retrieved from spleen of an immunized mouse
Ab production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Production of MAb myeloma cell

A

Propagation in vitro
No ab production
No HGPRT
No TK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Selection of the MAb

A

Select the viable clones with hypoxanthine aminopterin

Selection of clones producing the desired abs with immuno tests e.g ELISA, IF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Production of MAb

A

In vivo

In vitro

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Production of MAb: In vivo

A

Abdominal fluid
Possibility of contamination
Animal welfare considerations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Production of MAb: In vitro

A

Supernatant
Lower risk of contamination
Similar amounts can be obtained

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Labelling antibodies

A

Fab labelled or

Fc labelled

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Labelling antibodies: Fab labelled

A

Biclonal!
Effector cell and antigen
Fusion protein and antigen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Labelling antibodies: Fc labelled

I think these are used in therapy?

A
Drugs: tumors, autoimmune
Toxin: cytotoxic 
Cytokine: APC activity up
Radioactive substances: diagnostics and tumors 
Liposome: drug
Enzyme: diagnostics 
Fluorescent dye: diagnostics 
Biotin: diagnostics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Application od MAb

A

Research
Diagnostics
Therapy

17
Q

MAb diagnostics

A

Targets: bacteria, viruses, antibodies, tumors
Methods: ELISA, immunohistochem, immunofluorescence

18
Q

MAb therapy

A

Direct cytotoxicity or cell function modulation

19
Q

The dangers of MAb therapies

A

Short term: acute hyperreactivity- anaphylaxis
Long-term: elimination of the adaptive immune response

Solution: genetic engineering to produce humanized MAb
Use of ab fragments
Absence of Fc region reduces nonspecific binding

20
Q

MAb therapy: Mechanisms of action

A
Ligand binding 
Receptor blocking
Receptor down reg
Depletion
Signal induction
Apoptosis induction
Labelling with toxins or drugs
21
Q

MAb therapy: areas of application

A

Inflamm diseases
Autoimmune diseases
Infectious diseases
Tumors

22
Q

MAb in inflamm diseases

A

Chronic inflamm-
Psoriasis: combined cytokine neutralization anti-p40 ab
Chron’s disease, sclerosis multiplex: anti-integrin alpha4

23
Q

MAb in Autoimmune diseases, transplantation, tumours

A

Before organ transplatation, chronic lymphoid leukemia, T-cell lymphomas
Elimination of mature lymphocytes
Anti CD52 ab

24
Q

Cancer immunotherapy

A

Therapeutic vaccination
Active vaccination: injection of tumor antigens
Passive vaccinaiton: injection of ab or cells